What is CLMT's health score?

Calumet, Inc. /DE (CLMT) has a TradeApes health score of 44 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CLMT's estimated fair value?

Based on our 5-year discounted cash flow model, Calumet, Inc. /DE's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is CLMT undervalued or overvalued?

Our model currently rates CLMT as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CLMT... Refresh in a moment for the full analysis.

Calumet, Inc. /DE (CLMT)

Energy Inconclusive inconclusive weak

$37.37

Updated: 2026-06-03

TradeApes Score

Financial Strength

50 Mixed

Operating Trend

50 Mixed

Relative Value

15 Stressed

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.